Baugh & Associates, LLC Abb Vie Inc. Transaction History
Baugh & Associates, LLC
- $199 Million
- Q3 2024
A detailed history of Baugh & Associates, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Baugh & Associates, LLC holds 44,360 shares of ABBV stock, worth $7.52 Million. This represents 4.4% of its overall portfolio holdings.
Number of Shares
44,360
Previous 43,970
0.89%
Holding current value
$7.52 Million
Previous $7.54 Million
16.16%
% of portfolio
4.4%
Previous 4.12%
Shares
28 transactions
Others Institutions Holding ABBV
# of Institutions
3,817Shares Held
1.25BCall Options Held
13MPut Options Held
10M-
Vanguard Group Inc Valley Forge, PA172MShares$29.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.4 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.84 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.57 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $300B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...